二仙汤及加减方治疗骨质疏松症的研究进展
Research progress of Erxian Decoction and it addition and subtraction prescription for the treatment of osteoporosis
  
DOI:10.3969/j.issn.1006-7108.2018.12.018
中文关键词:  骨质疏松症  二仙汤  中医药  研究进展
英文关键词:osteoporosis  Erxian decoction  chinese medicine  research progress
基金项目:江苏省中医传统运动康复技术方案(K2017ykf08)
作者单位
陈世洲 毛国庆* 1.南京中医药大学第一临床医学院江苏 南京210046 2.南京中医药大学附属医院江苏 南京210029 
摘要点击次数: 1104
全文下载次数: 470
中文摘要:
      骨质疏松症因骨量减少,易于发生骨折而成为影响我国居民健康的一种重要因素。中医药方法诸如二仙汤等治疗骨质疏松症以其副作用小,标本兼顾的特点愈发成为临床的一种治疗趋势。笔者通过整理关于二仙汤及加减方的实验与临床研究,介绍二仙汤及加减方治疗骨质疏松症的显著疗效,并对研究的可取与相对不足之处作出讨论,希望未来医务工作者们对相关实验与临床的研究能够更加深入。同时,提出联合治疗等方式,以期二仙汤及加减方为代表的中医药方法能够在临床上更加广泛的运用于骨质疏松症的治疗。
英文摘要:
      Osteoporosis, characterized by bone loss and increase fracture risk, is an important factor that affects the health of Chinese people. Traditional Chinese medicine such as Erxian Decoction has become a trend of clinical treatment because it has less side effects and addresses both the symptoms and the root cause. By reviewing experimental and clinical studies of Erxian Decoction and its addition and subtraction prescription, the author introduces the curative effect of Erxian Decoction and its addition and subtraction prescription in the treatment of osteoporosis, and discusses the strength and relative shortcomings of the research, hoping that future medical workers will be more thorough in the related experimental and clinical research. At the same time, the method of combined treatment has been putting forward, so that traditional Chinese medicine, represented by Erxian Decoction and its addition and subtraction, can be used in the treatment of osteoporosis in clinical settings more widely.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=FC9DA7BF2F842A3BAE24B54F70914FE6E2B3E88187823C9B88B510514B973DCB20B25E1D0517FAA6DC211743CD14FEA7527EC6F2F9EE9E5B508F80E9966DF325F5DAD5D76B1993F60010188055850EDDB73E5B9BE8D392F815C8ED6578C2BCE5319556A76C26B5315D9F082EF23B66C08E6608204E020629&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=EA357AD73C8E13BC&aid=BC4A7A631EF4C4999F370421DC2B51F1&vid=&iid=59906B3B2830C2C5&sid=9036AC33107DC7C4&eid=F542EAAB80181084&fileno=201812018&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="EA357AD73C8E13BC"; var my_aid="BC4A7A631EF4C4999F370421DC2B51F1";